back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-10-20 15:00 Tx date 2023-10-18 |
$GTTX
GeneTether Therapeutics Inc. |
Sargent, Roy Geoffrey
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-10,421,974 vol |
775,000 | |
| Filed 2023-10-20 14:56 Tx date 2023-10-18 |
$GTTX
GeneTether Therapeutics Inc. |
Sargent, Roy Geoffrey
3 - 10% Security Holder of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-298,586 vol |
0 | |
| Filed 2023-09-29 17:38 Tx date 2023-09-22 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-1,051,249 vol |
1,859,964 | |
| Filed 2022-10-28 17:51 Tx date 2022-10-27 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$900.00
+5,000 vol $0.18 each |
135,000 | |
| Filed 2022-10-21 17:27 Tx date 2022-10-21 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$330.00
+1,500 vol $0.22 each |
130,000 | |
| Filed 2022-10-19 18:25 Tx date 2022-10-19 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+5,000 vol $0.20 each |
128,500 | |
| Filed 2022-10-17 17:20 Tx date 2022-10-14 |
$GTTX
GeneTether Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,250
+5,000 vol $0.25 each |
21,738,919 | |
| Filed 2022-10-17 13:05 Tx date 2022-10-14 |
$GTTX
GeneTether Therapeutics Inc. |
Graham, Daren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,099
+5,400 vol $0.2037 each |
2,431,508 | |
| Filed 2022-10-17 13:03 Tx date 2022-10-14 |
$GTTX
GeneTether Therapeutics Inc. |
Graham, Daren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,350
+5,400 vol $0.25 each |
||
| Filed 2022-10-12 13:35 Tx date 2022-10-11 |
$GTTX
GeneTether Therapeutics Inc. |
Pereira Fraga Figueiredo, Andre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$700.00
+2,500 vol $0.28 each |
2,563,061 | |
| Filed 2022-10-12 13:35 Tx date 2022-10-11 |
$GTTX
GeneTether Therapeutics Inc. |
Pereira Fraga Figueiredo, Andre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250.00
+1,000 vol $0.25 each |
2,560,561 | |
| Filed 2022-10-12 13:34 Tx date 2022-10-11 |
$GTTX
GeneTether Therapeutics Inc. |
Pereira Fraga Figueiredo, Andre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$375.00
+1,500 vol $0.25 each |
2,559,561 | |
| Filed 2022-10-05 12:09 Tx date 2022-10-03 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+5,000 vol $0.24 each |
123,500 | |
| Filed 2022-09-26 15:23 Tx date 2022-09-26 |
$GTTX
GeneTether Therapeutics Inc. |
Pereira Fraga Figueiredo, Andre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,917
+7,100 vol $0.27 each |
2,558,061 | |
| Filed 2022-09-22 13:32 Tx date 2022-09-22 |
$GTTX
GeneTether Therapeutics Inc. |
Pereira Fraga Figueiredo, Andre
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$270.00
+1,000 vol $0.27 each |
2,550,961 | |
| Filed 2022-09-09 17:07 Tx date 2022-09-09 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$110.00
+500 vol $0.22 each |
118,500 | |
| Filed 2022-09-09 17:07 Tx date 2022-09-08 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$330.00
+1,500 vol $0.22 each |
118,000 | |
| Filed 2022-09-08 12:39 Tx date 2022-09-08 |
$GTTX
GeneTether Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,760
+12,000 vol $0.23 each |
21,733,919 | |
| Filed 2022-08-30 11:10 Tx date 2022-08-29 |
$GTTX
GeneTether Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,224
+12,400 vol $0.26 each |
21,721,919 | |
| Filed 2022-08-29 16:39 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$650.00
+2,500 vol $0.26 each |
115,000 | |
| Filed 2022-08-29 16:39 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$550.00
+2,500 vol $0.22 each |
112,500 | |
| Filed 2022-08-29 16:38 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$375.00
+1,500 vol $0.25 each |
116,500 | |
| Filed 2022-08-29 16:37 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$400.00
+2,500 vol $0.16 each |
||
| Filed 2022-08-29 16:37 Tx date 2022-08-26 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$300.00
+2,500 vol $0.12 each |
||
| Filed 2022-03-29 12:40 Tx date 2022-03-29 |
$GTTX
GeneTether Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$4,117,553
+5,718,824 vol $0.72 each |
5,718,824 | |
| Filed 2022-03-29 12:40 Tx date 2022-03-21 |
$GTTX
GeneTether Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-29 12:39 Tx date 2022-03-29 |
$GTTX
GeneTether Therapeutics Inc. |
Garner, William James
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$3,431,294
+5,718,824 vol $0.60 each |
21,709,519 | |
| Filed 2022-03-29 12:32 Tx date 2022-03-29 |
$GTTX
GeneTether Therapeutics Inc. |
Graham, Daren
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$39,600
+55,000 vol $0.72 each |
55,000 | |
| Filed 2022-03-29 12:32 Tx date 2022-03-21 |
$GTTX
GeneTether Therapeutics Inc. |
Graham, Daren
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-29 12:32 Tx date 2022-03-29 |
$GTTX
GeneTether Therapeutics Inc. |
Graham, Daren
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$33,000
+55,000 vol $0.60 each |
2,426,108 | |
| Filed 2022-03-29 12:28 Tx date 2022-03-29 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$79,200
+110,000 vol $0.72 each |
110,000 | |
| Filed 2022-03-29 12:27 Tx date 2022-03-21 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-29 12:26 Tx date 2022-03-29 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$66,000
+110,000 vol $0.60 each |
110,000 | |
| Filed 2022-03-29 11:37 Tx date 2022-03-21 |
$GTTX
GeneTether Therapeutics Inc. |
Boivin, Roland
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|